-
July 16: The Week in Cancer NewsA study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.
by Bradley Jones
-
Moving Away From the Maximum Tolerated DoseThe FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
-
July 2: The Week in Cancer NewsA study sheds light on the link between red meat consumption and colorectal cancer, and mRNA COVID-19 vaccines are effective in most cancer patients.
by Kevin McLaughlin
-
From the Editor-in-Chief
The Tumor MicroenvironmentResearch is leading to treatments that target cancer's support system.
by William G. Nelson, MD, PhD
-
Forward Look
First CAR-T Cell Therapy Approved for Multiple MyelomaCellular immunotherapies can offer periods when people do not require treatment.
by Christina Bennett
-
Forward Look
Going FlatMost people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.
by Kris Conner
-
Forward Look
The Impact of HPV VaccinationOver a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent.
by Carisa D. Brewster
-
Forward Look
What’s Next? Summer 2021Using fecal transplants to improve immunotherapy response
by Natalie Slivinski
-
Are You a Candidate for Immunotherapy?Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.
by Kendall K. Morgan
-
A Fast Track for Cancer VaccinesThe rapid development of mRNA COVID-19 vaccines could spark advances in similar treatments for cancer.
by Stephen Ornes
After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore
AACR Annual Meeting 2025Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
